Global Neurology Academy

Genetic Testing in Pediatrics: Identifying Neurodevelopmental Disorders Early
Genetic Testing in Pediatrics: Identifying Neurodevelopmental Disorders Early
Clinician's Roundtable
Genetic Testing in Pediatrics: Identifying Neurodevelopmental Disorders Early
- Jennifer M. Kalish, MD, PhD, FAAP
Navigating MS Diagnosis in Older Adults: Distinguishing Comorbidities and Mimics
Navigating MS Diagnosis in Older Adults: Distinguishing Comorbidities and Mimics
NeuroFrontiers
Navigating MS Diagnosis in Older Adults: Distinguishing Comorbidities and Mimics
- Le Hua, MD
Genetic Pathways in MS: The Clinical Impact of a Chromosome 2 Variant
Genetic Pathways in MS: The Clinical Impact of a Chromosome 2 Variant
NeuroFrontiers
Genetic Pathways in MS: The Clinical Impact of a Chromosome 2 Variant
- Sergio Baranzini, PhD
From Resistance to Response: Evolving Strategies in MDD Management
From Resistance to Response: Evolving Strategies in MDD Management
CME/CE Broadcast Replay
From Resistance to Response: Evolving Strategies in MDD Management
1.00 credit
- Joseph F. Goldberg, MD
1.00 credit
Advances in Alzheimer’s Diagnosis: From Imaging to Artificial Intelligence
Advances in Alzheimer’s Diagnosis: From Imaging to Artificial Intelligence
NeuroFrontiers
Advances in Alzheimer’s Diagnosis: From Imaging to Artificial Intelligence
- Marc Haut, PhD
Addressing Barriers to MenB and MenACWY Vaccination
Addressing Barriers to MenB and MenACWY Vaccination
Global Neurology Academy
Addressing Barriers to MenB and MenACWY Vaccination
Advances in the Treatment of Neuropsychiatric Symptoms of Alzheimer's Disease: Early Recognition, Diagnosis, and Innovative Emerging Therapies
Advances in the Treatment of Neuropsychiatric Symptoms of Alzheimer's Disease: Early Recognition, Diagnosis, and Innovative Emerging Therapies
CME/CE
Advances in the Treatment of Neuropsychiatric Symptoms of Alzheimer's Disease: Early Recognition, Diagnosis, and Innovative Emerging Therapies
1.00 credit
- Marwan Sabbagh, MD, FAAN
- Alireza Atri, MD, PhD
- Christoph U. Correll, MD
1.00 credit
Evaluating MenB Vaccines Beyond the Traditional hSBA Assay
Evaluating MenB Vaccines Beyond the Traditional hSBA Assay
Global Neurology Academy
Evaluating MenB Vaccines Beyond the Traditional hSBA Assay

Medical News

Medical News
AI Rewrites the Rules of Multiple Sclerosis: Study Recasts MS as a Disease Continuum
10/07/2025
Read more
Medical News
Early Vision Therapy Speeds Recovery From Concussion-Related Eye Disorders, Trial Finds
10/07/2025
Read more
Medical News
Aging Brain Reveals Hidden Patterns of Geometric Restructuring Linked to Cognitive Decline
10/06/2025
Read more
Medical News
Engineered Peptide Blocks Alpha-Synuclein Aggregation, Offering Hope for Parkinson’s Disease Therapies
10/06/2025
Read more

See more news

CME/CE

CME/CE Meeting
Advancing Myasthenia Gravis (MG) Treatment Through Guideline Updates and Emerging Therapies
October 30, 2025
San Francisco, California
1.00 credit Learn more
Treatment Advances in Generalized Myasthenia Gravis: A Pathophysiology-Driven Framework Leveraging FcRn Therapeutics
Treatment Advances in Generalized Myasthenia Gravis: A Pathophysiology-Driven Framework Leveraging FcRn Therapeutics
CME/CE
Treatment Advances in Generalized Myasthenia Gravis: A Pathophysiology-Driven Framework Leveraging FcRn Therapeutics
0.75 credits
- Vera Bril, MD
- Neelam Goyal, MD
0.75 credits
A Scientific Look at FcRn Antagonists: Mechanisms of Action Explained
A Scientific Look at FcRn Antagonists: Mechanisms of Action Explained
MinuteCE®
A Scientific Look at FcRn Antagonists: Mechanisms of Action Explained
1.00 program credit
- Vera Bril, MD
- Nicholas J. Silvestri, MD
1.00 program credit
Treatment Advances in Generalized Myasthenia Gravis: Clinical and Laboratory Criteria for Diagnosis and Optimal Treatment Selection
Treatment Advances in Generalized Myasthenia Gravis: Clinical and Laboratory Criteria for Diagnosis and Optimal Treatment Selection
CME/CE
Treatment Advances in Generalized Myasthenia Gravis: Clinical and Laboratory Criteria for Diagnosis and Optimal Treatment Selection
0.75 credits
- Vera Bril, MD
- Jonathan Strober, MD
0.75 credits

Clinical Practice

Modern MS Management: Leveraging Technology to Support Brain Health
Modern MS Management: Leveraging Technology to Support Brain Health
Global Neurology Academy
Modern MS Management: Leveraging Technology to Support Brain Health
- Victoria Leavitt, PhD
- Gates B. Colbert, MD
Timing Matters: Influenza Vaccination Response in MS Patients on Ofatumumab
Timing Matters: Influenza Vaccination Response in MS Patients on Ofatumumab
NeuroFrontiers
Timing Matters: Influenza Vaccination Response in MS Patients on Ofatumumab
Clemastine Fumarate and Progressive MS: A Closer Look at Unexpected Risks and Mechanisms
Clemastine Fumarate and Progressive MS: A Closer Look at Unexpected Risks and Mechanisms
NeuroFrontiers
Clemastine Fumarate and Progressive MS: A Closer Look at Unexpected Risks and Mechanisms
Pregnancy and Infant Outcomes in Multiple Sclerosis: Findings From the MAPLE-MS Pharmacovigilance Program
Pregnancy and Infant Outcomes in Multiple Sclerosis: Findings From the MAPLE-MS Pharmacovigilance Program
NeuroFrontiers
Pregnancy and Infant Outcomes in Multiple Sclerosis: Findings From the MAPLE-MS Pharmacovigilance Program

Programs

Decoding Disability Worsening in MS: The Case for Combining CSF and Serum Biomarkers
Decoding Disability Worsening in MS: The Case for Combining CSF and Serum Biomarkers
NeuroFrontiers
Decoding Disability Worsening in MS: The Case for Combining CSF and Serum Biomarkers
- Ryan Quigley
The Future of MS Management: Novel Agents and Clinical Approaches
The Future of MS Management: Novel Agents and Clinical Approaches
NeuroFrontiers
The Future of MS Management: Novel Agents and Clinical Approaches
- Marisa McGinley, DO
Recognizing MS: Understanding Symptoms and Avoiding Misdiagnosis
Recognizing MS: Understanding Symptoms and Avoiding Misdiagnosis
NeuroFrontiers
Recognizing MS: Understanding Symptoms and Avoiding Misdiagnosis
Modern MS Care: Navigating Treatment Options for Better Patient Outcomes
Modern MS Care: Navigating Treatment Options for Better Patient Outcomes
NeuroFrontiers
Modern MS Care: Navigating Treatment Options for Better Patient Outcomes